Mgmt expression correlates with response rate and survival in patients with inoperable glioblastoma (GBM) treated with neoadjuvant temozolomide (TMZ)

被引：0
|
作者：
Barrie, M.
Eudes, N.
Boucard, C.
Metellus, P.
Fuentes, S.
Honoré, S.
Dufour, H.
Figarella-Branger, D.
Chinot, O.
机构：
[1] CHU Timone, Marseille, France
[2] Fac Med Nord, Marseille, France
来源：
NEURO-ONCOLOGY | 2006年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：352 / 352
页数：1
相关论文
共 50 条
  • [1] MGMT expression correlates with response rate and survival in patients with inoperable glioblastoma (GBM) treated with neoadjuvant temozolomide (TMZ).
    Barrie, M.
    Eudes, N.
    Metellus, P.
    Fuentes, S.
    Honore, S.
    Boucard, C.
    Dufour, H.
    Figarella-Branger, D.
    Chinot, O.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 76S - 76S
  • [2] THE IMPACT OF MISMATCH REPAIR DEFICIENCY (MMRD) ON SURVIVAL OF TEMOZOLOMIDE (TMZ)-TREATED PATIENTS WITH MGMT METHYLATED (M-MGMT) GLIOBLASTOMA (GBM): A CELLWORKS COMPUTATIONAL BIOSIMULATION PILOT STUDY
    Castro, Michael
    Iwamoto, Fabio
    Ahluwalia, Manmeet
    Usmani, Shahabuddin
    Kumar, Ansu
    Kapoor, Shweta
    Suseela, Rakhi Purushothaman
    Kulkarni, Shruthi
    Mohanty, Jharana
    Shyamasundar, Vijayashree
    Ghosh, Adity
    Prasad, Nagendra
    Patil, Mamatha
    Choudhury, Sayantani Roy
    Chauhan, Jyoti
    Sauban, Mohammed
    Joseph, Vishwas
    Kumari, Pallavi
    Mitra, Upasana
    Pampana, Anusha
    Azam, Humera
    Poornachandra, G.
    Prakash, Annapoorna
    Basu, Sayani
    NEURO-ONCOLOGY, 2022, 24 : 116 - 117
  • [3] RETROSPECTIVE ANALYSIS OF GLIOBLASTOMA (GBM) PATIENTS TREATED WITH TEMOZOLOMIDE (TMZ)-RADIOTHERAPY FOLLOWED BY TMZ FOR 2 YEARS OR UNTIL PROGRESSION: SURVIVAL ANALYSIS
    Muggeri, Alejandro D.
    Alderuccio, Juan Pablo
    Martinetto, Horacio
    Diez, Blanca D.
    NEURO-ONCOLOGY, 2009, 11 (06) : 948 - 948
  • [4] BIOMARKER IMMUNE CORRELATES IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) TREATED WITH ATEZOLIZUMAB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) AND RADIATION
    Weathers, Shiao-Pei
    Knafl, Mark
    Parra, Edwin
    Hernandez, Sharia
    Solis, Luisa
    Espiridion, Beatriz Sanchez
    Wistuba, Ignacio
    Futreal, Andrew
    Maru, Dipen
    Kamiya-Matsuoka, Carlos
    Harrison, Rebecca
    Joseph, Victory
    Yun, Cindy
    Darbonne, Walter
    Loghin, Monica
    Penas-Prado, Marta
    Majd, Nazanin
    Yung, W. K. Alfred
    O'Brien, Barbara
    Scott, Woodman
    DeGroot, John
    NEURO-ONCOLOGY, 2021, 23 : 49 - 49
  • [5] Predictive role of MGMT status in recurrent glioblastoma (GBM) patients (PTS) treated with antiangiogenic drug (AD) plus temozolomide (TMZ) or CPT-11.
    Lombardi, Giuseppe
    Zustovich, Fable
    Farina, Patrizia
    Bertorelle, Roberta
    Della Puppa, Alessandro
    Gardiman, Marina Paola
    Fiduccia, Pasquale
    D'Avella, Domenico
    Zagonel, Vittorina
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Postmortem evaluation of end-organ toxicity in patients with glioblastoma (GBM) treated with temozolomide (TMZ) and bevacizumab (BEV).
    Zhu, J.
    Tian, X. J.
    Linendoll, N.
    Pfannl, R.
    Pilichowska, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [7] EARLY INITIATION OF RADIOTHERAPY PLUS CONCOMITANT AND ADJUVANT TEMOZOLOMIDE (TMZ) AND OVERALL SURVIVAL (OS) IN GLIOBLASTOMA (GBM) PATIENTS
    Roessler, K.
    Muxel, M.
    Zachenhofer, I.
    Maier, R.
    DeVries, A.
    NEURO-ONCOLOGY, 2010, 12 : 48 - 48
  • [8] Outcome of grade 3 and 4 cytopenia in newly diagnosed glioblastoma multiforme (GBM) patients treated with temozolomide (TMZ).
    Sanchez, B. E.
    Munoz, J.
    Ali, H. Y.
    Anderson, J. M.
    Kuriakose, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Combination chemotherapy versus temozolomide (TMZ) for patients with MGMT methylated (m-MGMT) glioblastoma (GBM): Results of cellworks omics biosimulation-MyCare-015.
    Castro, Michael
    Mundkur, Nirjhar
    Pampana, Anusha
    Alam, Aftab
    Alam, Aktar
    Parashar, Rajan
    Rajagopalan, Swaminathan
    Lala, Deepak Anil
    Roy, Kunal Ghosh Ghosh
    Basu, Sayani
    Prakash, Annapoorna
    Nair, Prashant
    Christie, Jim
    Joseph, Vishwas
    Agarwal, Ashish
    Poornachandra, G.
    Behura, Liptimayee
    Kulkarni, Shruthi
    Choudhary, Nikita Ray
    Kapoor, Shweta
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] A randomized phase II trial of veliparib (V), radiotherapy (RT) and temozolomide (TMZ) in patients (pts) with unmethylated MGMT (uMGMT) glioblastoma (GBM).
    Khasraw, Mustafa
    McDonald, Kerrie Leanne
    Rosenthal, Mark
    Lwin, Zarnie
    Ashley, David M.
    Wheeler, Helen
    Barnes, Elizabeth
    Foote, Matthew C.
    Koh, Eng-Siew
    Sulman, Erik P.
    Back, Michael
    Buckland, Michael
    Sim, Hao-Wen
    Fisher, Lauren
    Leonard, Robyn
    Hall, Merryn
    Yip, Sonia
    Simes, John
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345